AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

130_rns_2026-01-12_84cd4706-52ff-4b11-ae97-69a9f87b0b41.html

AGM Information

Open in Viewer

Opens in native device viewer

News Details

Corporate | 12 January 2026 14:56

Eckert & Ziegler to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Eckert & Ziegler SE / Key word(s): Conference

Eckert & Ziegler to Participate in the 44th Annual J.P. Morgan Healthcare Conference

12.01.2026 / 14:56 CET/CEST

The issuer is solely responsible for the content of this announcement.


Berlin, 12 January 2026. Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, 14 January 2026, at the Westin St. Francis in San Francisco, CA, USA. Dr Harald Hasselmann, CEO of Eckert & Ziegler SE, will present the company at 17:15 PST.

The presentation will be available as an audio livestream on the company’s website: https://www.ezag.com/investors/presentations/

After the event, the recording will be available for approximately 30 days.

About Eckert & Ziegler.

Eckert & Ziegler SE, with more than 1.000 employees, is a leading specialist for isotope-related components in nuclear medicine and radiation therapy. The company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDAX index of Deutsche Börse.

Contributing to saving lives.

Your contact:

Eckert & Ziegler SE, Karolin Riehle, Investor Relations

Robert-Rössle-Str. 10, 13125 Berlin, Germany

Tel.: +49 (0) 30 / 94 10 84-138, [email protected] , www.ezag.com


12.01.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group .

The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.


Language: English
Company: Eckert & Ziegler SE
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: +49 30 941084-138
Fax: +49 30 941084-0
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Indices: SDAX, TecDax,
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2258654
End of News EQS News Service

2258654  12.01.2026 CET/CEST

Talk to a Data Expert

Have a question? We'll get back to you promptly.